Annotated Bibliography_Final.pdf - AHRQ National Resource ...

Annotated Bibliography
In the order of appearance:
Nidhi R. Shah, MD, MPH, Andrew C. Seger, PharmD, Diane L. Seger, RPh, Julie M. Fiskio, BS, Gilad J.
Kuperman, MD, PhD, Barry Blumenfeld, MD, Elaine G. Recklet, BSN, David W. Bates, MD, MSc and Tejal K.
Gandhi, MD, MPH. Improving Acceptance of Computerized Prescribing Alerts in Ambulatory Care. J. Am. Med.
Inform. Assoc. 2006;13:5-11. DOI 10.1197/jamia.M1868.
Robert A. Raschke, MD, MS; Bea Gollihare, MS, RN; Thomas A. Wunderlich, RPh; James R. Guidry, PharmD,
BCPS; Alan I. Leibowitz, MD; John C. Peirce, MD, MA, MS; Lee Lemelson, RPh; Mark A. Heisler, PharmD; Cynthia
Susong, RN, MS. A Computer Alert System to Prevent Injury From Adverse Drug Events. JAMA. 1998;280:1317-
1320.
David W. Bates, Jonathan M. Teich, Joshua Lee, Diane Seger, Gilad J. Kuperman, Nell Ma''Luf, Deborah Boyle,
Lucian Leape. The Impact of Computerized Physician Order Entry on Medication Error Prevention. J. Am. Med.
Inform. Assoc.1999; 6: 313-321.
R. Scott Evans, Ph.D., Stanley L. Pestotnik, M.S., R.Ph., David C. Classen, M.D., M.S., Terry P. Clemmer, M.D.,
Lindell K. Weaver, M.D., James F. Orme, M.D., James F. Lloyd, B.S., and John P. Burke, M.D. A Computer-
Assisted Management Program for Antibiotics and Other Antiinfective Agents .N. Engl. J. Med. 1998; 338:1775-
1776, Jun 11, 1998.
Josh F. Peterson, MD, MPH; Gilad J. Kuperman, MD, PhD; Caroline Shek, RPh; Minalkumar Patel, MD, MPH;
Jerry Avorn, MD; David W. Bates, MD, MSc. Guided Prescription of Psychotropic Medications for Geriatric
Inpatients. Arch Intern Med. 2005;165:802-807.
Fischer MA, Lilly CM, Churchill WW, Baden LR, Avorn J. An algorithmic computerised order entry approach to
assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical
centre. Drug Safety. 2004;27:1253–61.

Alan J. Forster, Harvey J. Murff, Josh F. Peterson, Tejal K. Gandhi, David W. Bates. Adverse Drug Events
Occurring Following Hospital Discharge. J Gen Int Med. Published Online: 2005. DOI: 10.1111/j.1525-
1497.2005.30390.x
Thomas Isaac, MD, MBA, MPH; Joel S. Weissman, PhD; Roger B. Davis, ScD; Michael Massagli, PhD; Adrienne
Cyrulik, MPH; Daniel Z. Sands, MD, MPH; Saul N. Weingart, MD, PhD. Overrides of Medication Alerts in
Ambulatory Care. Arch Intern Med.2009; 169: 305-311.
Saul N. Weingart; Maria Toth; Daniel Z. Sands; Mark D. Aronson; Roger B. Davis; Russell S. Phillips. Physicians'
Decisions to Override Computerized Drug Alerts in Primary Care.
Arch Intern Med, Nov 2003; 163: 2625 - 2631.
Lapane KL, Waring ME, Schneider KL, Dubé C, Quilliam BJ. A Mixed Method Study of the Merits of E-Prescribing
Drug Alerts In Primary Care. J Gen Intern Med. 2008 Apr;23(4):442-6.
First set of recommendations of e-prescribing standards. 2004. (Accessed October 11, 2005 at
http://www.ncvhs.hhs.gov)
EA Flynn, KN Barker, JT Gibson, RE Pearson, BA Berger, and LA Smith. Impact of interruptions and distractions
on dispensing errors in an ambulatory care pharmacy. Am. J. Health Syst. Pharm., Jul 1999; 56: 1319 - 1325.
Jennifer S. Haas, Kathryn A. Phillips, Eric P. Gerstenberger, and Andrew C. Seger. Potential Savings from
Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000. Ann Intern
Med., Jun 2005; 142: 891 - 897.
Michael A. Fischer, MD, MS; Jerry Avorn, M. Economic Implications of Evidence-Based Prescribing for
Hypertension: Can Better Care Cost Less? JAMA. 2004;291:1850-1856.
William H. Shrank, MD, MSHS; Tuyen Hoang, PhD; Susan L. Ettner, PhD; Peter A. Glassman, MBBS, MSc; Kavita
Nair, PhD; Dee DeLapp, RPh; June Dirstine; Jerry Avorn, MD; Steven M. Asch, MD, MPH. The Implications of
Choice: Prescribing Generic or Preferred Pharmaceuticals Improves Medication Adherence for Chronic Conditions.
Arch Intern Med. 2006;166:332-337.

Fischer MA, Vogeli C, Stedman M, et al. Effect of electronic prescribing with formulary decision support on
medication use and cost. Arch Intern Med. 2008;168(22):2433–2439
D. Gans, J. Kralewski, T. Hammons, and B. Dowd. Medical Groups' Adoption Of Electronic Health Records And
Information Systems. Health Aff., September 1, 2005; 24(5): 1323 - 1333.
Fischer MA, Vogeli C, Stedman M, Ferris T, Weissman J. Uptake of electronic prescribing in community-based
practices. J Gen Intern Med. 2008; 23: DOI 10.1007/s11606-007-0383-1.
Alliance of States with Prescription Monitoring Programs, 1999. http://www.nascsa.org/Alliance/PDF/Goals.PDF
U.S. Drug Enforcement Administration, Initial Economic Impact Analysis of the Proposed Electronic Prescription
Rule, April 2008, www.deadiversion.usdoj.gov.
IMS Health, IMS National Prescription Audit, 2008, www.imsheatlh.com.
U.S. Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, 2006,
www.samhsa.gov.
DEA Notice of Proposed Rulemaking. Federal Register: June 27, 2008, v.73, no. 125, pp. 36721-36782.
Thomas, C.P. et al., Enabling Electronic Prescribing for Controlled Substances: Perspectives of Physicians and
Other Prescribers, Poster Presentation, AHRQ 2009 Annual Conference, September, 2009.
Florida . Statutes, Chapter 893.
Texas . Administrative. Code, Title 22, §291.34
Texas. Health & Safety Code, Chapter 481